ARTICLE

FindCenter AddIcon

For the First Time, Scientists Have Imaged the Brain on LSD

By Victoria Turk — 2016

The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.

Read on www.vice.com

FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

Article
Emily Witt
2021
FindCenter AddIcon
FindCenter Post-Image

Meet the Psychologist Using Psychedelics to Treat Racial Trauma

People of color are dealing with racism all the time, in large and small ways, and even dealing with racism in healthcare, even dealing with racism in therapy.

Article
Robin Donovan
2021
FindCenter AddIcon
FindCenter Post-Image

How Should We Do Drugs Now?

While we can now begin to glimpse an end to the drug war, it is much harder to envision what the drug peace will look like. How will we fold these powerful substances into our society and our lives so as to minimize their risks and use them most constructively?

Article
Michael Pollan
2021
FindCenter AddIcon
FindCenter Post-Image

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.

After decades of demonization and criminalization, psychedelic drugs are on the cusp of entering mainstream psychiatry, with profound implications for a field that in recent decades has seen few pharmacological advancements for the treatment of mental disorders and addiction.

Article
Andrew Jacobs
2021
FindCenter AddIcon
FindCenter Post-Image

Could the Embrace of Psychedelics Lead to a Mental-Health Revolution?

The last time I was on ketamine, I was hooked up to an IV following surgery. This time, the drug—in general medical use as an anesthetic since 1970—arrived on my doorstep courtesy of Mindbloom, a new telemedicine company specializing in ketamine-based psychedelic therapy.

Article
Maya Singer
2021
FindCenter AddIcon
FindCenter Post-Image

The Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results.

Article
Michael Pollan
2015
FindCenter AddIcon
FindCenter Post-Image

Why Canada Could Be Next to Allow Psychedelic Therapy (And How It’s Already Changing Lives)

Now, as a handful of patients and more recently doctors and therapists have been granted exemptions to use psilocybin, the nation’s federal health agency is considering making changes to existing policies that could open the door to much more than magic mushrooms.

Article
Amanda Siebert
2020
FindCenter AddIcon
FindCenter Post-Image

Psychedelic Drugs Can Help Treat PTSD Caused by Racism, Discrimination: Researchers

Williams is the co-lead author of a recent retrospective study that found those who tried doses of psilocybin (more commonly known as magic mushrooms), LSD, or MDMA (the pure substance found in Ecstasy or Molly) reported a decrease in trauma symptoms, depression and anxiety after 30 days.

Article
Avis Favaro, Elizabeth St. Philip, Solarina Ho
2021
FindCenter AddIcon
FindCenter Post-Image

How Ecstasy and Psilocybin Are Shaking Up Psychiatry

Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.

Article
Paul Tullis
2021
FindCenter AddIcon
FindCenter Post-Image

Johns Hopkins Scientists Give Psychedelics the Serious Treatment

Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look.

Article
Tanya Lewis
2020
FindCenter AddIcon

EXPLORE TOPIC

LSD